Physical activity in a cohort of HIV-positive and HIV-negative injection drug users

AIDS Care - Psychological and Socio-Medical Aspects of AIDS/HIV

Volumn 18, Issue 8, 2006, Pages 1040-1045

  Smit, Ellen ^a,b   Crespo, C J ^a,b   Semba, R D ^c   Jaworowicz, D ^b   Vlahov, D ^d,e   Ricketts, E P ^d   Ramirez Marrero, F A ^f   Tang, A M ^g  

^a PORTLAND STATE UNIVERSITY   (United States)

^b UNIVERSITY AT BUFFALO   (United States)

^c JOHNS HOPKINS UNIVERSITY SCHOOL OF MEDICINE   (United States)

^d JOHNS HOPKINS BLOOMBERG SCHOOL OF PUBLIC HEALTH   (United States)

^e NEW YORK ACADEMY OF MEDICINE   (United States)

^f UNIVERSITY OF PUERTO RICO   (Puerto Rico)

^g TUFTS UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

COCAINE; DIAMORPHINE; ILLICIT DRUG;

ADULT; ANTHROPOMETRY; ARTICLE; COMPARATIVE STUDY; CONTROLLED STUDY; DRUG USE; ENERGY EXPENDITURE; FEMALE; HIGHLY ACTIVE ANTIRETROVIRAL THERAPY; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTED PATIENT; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; INJECTION DRUG USE; INTERVIEW; MAJOR CLINICAL STUDY; MALE; PAFFENBARGER PHYSICAL ACTIVITY QUESTIONNAIRE; PHYSICAL ACTIVITY; PRIORITY JOURNAL; QUESTIONNAIRE; STATISTICAL MODEL; UNIVARIATE ANALYSIS; VIRUS LOAD;

ADULT; ANTIRETROVIRAL THERAPY, HIGHLY ACTIVE; COHORT STUDIES; CROSS-SECTIONAL STUDIES; ENERGY METABOLISM; EXERCISE; FEMALE; HIV SERONEGATIVITY; HIV SEROPOSITIVITY; HUMANS; MALE; MIDDLE AGED; SUBSTANCE ABUSE, INTRAVENOUS;

EID: 33749495191     PISSN: 09540121     EISSN: 13600451     Source Type: Journal    
DOI: 10.1080/09540120600580926     Document Type: Article

References (26)

1. Aberg, J.A. (2003). Cardiovascular risk among HIV-positive patients on antiretroviral therapy. Journal of International Association of Physicians in AIDS Care (Chic. Ill.). 2(Suppl 2), S24-S39.
2. Ainsworth, B.E., Leon, A.S., Richardson, M.T., Jacobs, D.R., & Paffenbarger, R.S. Jr. (1993). Accuracy of the College Alumnus Physical Activity Questionnaire. Journal of Clinical Epidemiology, 46, 1403-1411.
3. Ainsworth, B.E., Haskell, W.L., Whitt, M.C., Irwin, M.L., Swartz, A.M., Strath, S.J., et al. (2000). Compendium of physical activities: An update of activity codes and MET intensities. Medicine and Science Sports and Exercise, 32, S498-S504.
4. Bergersen, B.M., Sandvik, L., Bruun, J.N., & Tonstad, S. (2004). Elevated Framingham risk score in HIV-positive patients on highly active antiretroviral therapy: Results from a Norwegian study of 721 subjects. European Journal of Clinical Microbiology & Infectious Diseases, 23, 625-630.
5. Bernell, S.L., & Shinogle, J.A. (2005). The relationship between HAART use and employment for HIV-positive individuals: An empirical analysis and policy outlook. Health Policy, 71, 255-264.
6. Bopp, C.M., Phillips, K.D., Fulk, L.J., Dudgeon, W.D., Sowell, R., & Hand, G.A. (2004). Physical activity and immunity in HIV-infected individuals. AIDS Care, 16, 387-393.
7. Cade, W.T., Peralta, L., & Keyser, R.E. (2002). Aerobic capacity in late adolescents infected with HIV and controls. Pediatric Rehabilitation, 5, 161-169.
8. Cade, W.T., Fantry, L.E., Nabar, S.R., Shaw, D.K., & Keyser, R.E. (2003a). A comparison of Qt and a-vO2 in individuals with HIV taking and not taking HAART. Medicine and Science in Sports and Exercise, 35, 1108-1117.
9. Cade, W.T., Fantry, L.E., Nabar, S.R., Shaw, D.K., & Keyser, R.E. (2003b). Impaired oxygen on-kinetics in persons with human immunodeficiency virus are not due to highly active antiretroviral therapy. Archives of Physical Medicine and Rehabilitation, 84, 1831-1838.
10. Cade, W.T., Peralta, L., & Keyser, R.E. (2004). Aerobic exercise dysfunction in human immunodeficiency virus: A potential link to physical disability. Physical Therapy, 84, 655-664.
11. Center for Disease Control and Prevention (2003). HIV/AIDS Surveillance Report , 15, 1-46.
12. Clingerman, E. (2004). Physical activity, social support and health-related quality of life among persons with HIV disease. Journal of Community Health Nursing, 21, 179-197.
13. Dudgeon, W.D., Phillips, K.D., Bopp, C.M., & Hand, G.A. (2004). Physiological and psychological effects of exercise interventions in HIV disease. AIDS Patient Care and STDS, 18, 81-98.
14. Goldman, D.P., & Bao, Y. (2004). Effective HIV treatment and the employment of HIV(positive) adults. Health Services Research, 39, 1691-1712.
15. Keyser, R.E., Peralta, L., Cade, W.T., Miller, S., & Anixt, J. (2000). Functional aerobic impairment in adolescents seropositive for HIV: A quasiexperimental analysis. Archives of Physical Medicine and Rehabilitation, 81, 1479-1484.
16. Marques-Magallanes, J.A., Koyal, S.N., Cooper, C.B., Kleerup, E.C., & Tashkin, D.P. (1997). Impact of habitual cocaine smoking on the physiologic response to maximum exercise. Chest, 112, 1008-1016.
17. Mustafa, T., Sy, F.S., Macera, C.A., Thompson, S.J., Jackson, K.L., Selassie, A., et al. (1999). Association between exercise and HIV disease progression in a cohort of homosexual men. Annals of Epidemiology, 9, 127-131.
18. Nanavati, K.A., Fisher, S.D., Miller, T.L., & Lipshultz, S.E. (2004). HIV-related cardiovascular disease and drug interactions. American Journal of Cardiovascular Drugs: Drugs, Devices, and other Interventions, 4, 315-324.
19. O'Brien, K., Nixon, S., Glazier, R.H., & Tynan, A.M. (2004). Progressive resistive exercise interventions for adults living with HIV/AIDS. Cochrane Database of Systematic Reviews, 18, 4 CD00 4248. (http://www.mrw. interscience.wiley.com/cochrane/clsysrev/articles/CD004248/frame.html).
20. Rusch, M., Nixon, S., Schilder, A., Braitstein, P., Chan, K., & Hogg, R.S. (2004). Impairments, activity limitations and participation restrictions: Prevalence and associations among persons living with HIV/AIDS in British Columbia. Health and Quality of Life Outcomes, 2, 46.
21. Shephard, R.J. (1998). Exercise, immune function and HIV infection. Journal of Sports Medicine & Physical Fitness, 38(2), 101-110.
22. Smit, E., Semba, R.D., Pilibosian, E., Vlahov, D., Tun, W., Purvis, L., & Tang, A.M. (2005). Body habitus in a cohort of HIV-positive and HIV-negative injection drug users. AIDS Patient Care and STDS, 19, 19-30.
23. Swain, D.P., & Franklin, B.A. (2006). Comparison of cardioprotective benefits of vigorous versus moderate intensity aerobic exercise. American Journal of Cardiology, 97, 141-147.
24. US Department of Health and Human Services (1996). Physical activity and health: A report of the surgeon general. Atlanta, GA: Center for Disease Control and Prevention.
25. Vlahov, D., Anthony, J.C., Munoz, A., Margolick, J., Nelson, K.E., Celentano, D.D., et al. (1991). The Alive Study: A longitudinal-study of Hiv-1 infection in intravenous drug users- description of methods. Journal of Drug Issues, 21, 759-776.
26. Wadsworth, E.J., Moss, S.C., Simpson, S.A., & Smith, A.P. (2004). Factors associated with recreational drug use. Journal of Psychopharmacology, 18, 238-248.